Search research articles
Contact Us
Filters
Showing results (401-410 of 437) with videos related to
Page
of 44
Sort By:
The British Journal of Ophthalmology
|
May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial
Felix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology
|
August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trial
Felix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
The Lancet. Psychiatry
|
August 7, 2025
Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany
Christian Plewnia, Bettina Brendel, Tobias Schwippel, et al.
Obesity (Silver Spring, Md.)
|
April 13, 2026
Determinants of Parents' and Adolescents' Motivation Before Pediatric Weight Management-Data From the STARKIDS Cohort
Anne Herschbach, Rebecca Erschens, Florian Junne, et al.
Lancet (London, England)
|
March 4, 2017
Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting
Caterina Breitenstein, Tanja Grewe, Agnes Flöel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Ophthalmic Research
|
November 28, 2019
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa: A Multicenter Safety Study of the OkuStim® System (TESOLA-Study)
Jasleen K Jolly, Siegfried K Wagner, Peter Martus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Ebiomedicine
|
November 12, 2025
Blood-brain barrier opening as a predictor of epilepsy and mortality after subarachnoid haemorrhage
Jens P Dreier, Svetlana Lublinsky, Viktor Horst, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 5, 2023
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury
Jan M Schwab, Carmen Haider, Marcel A Kopp, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 437) with videos related to
Sort By:
Page
of 44
The British Journal of Ophthalmology
|
May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial
Felix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
The British Journal of Ophthalmology
|
August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trial
Felix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
The Lancet. Psychiatry
|
August 7, 2025
Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany
Christian Plewnia, Bettina Brendel, Tobias Schwippel, et al.
Obesity (Silver Spring, Md.)
|
April 13, 2026
Determinants of Parents' and Adolescents' Motivation Before Pediatric Weight Management-Data From the STARKIDS Cohort
Anne Herschbach, Rebecca Erschens, Florian Junne, et al.
Lancet (London, England)
|
March 4, 2017
Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting
Caterina Breitenstein, Tanja Grewe, Agnes Flöel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Ophthalmic Research
|
November 28, 2019
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa: A Multicenter Safety Study of the OkuStim® System (TESOLA-Study)
Jasleen K Jolly, Siegfried K Wagner, Peter Martus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Ebiomedicine
|
November 12, 2025
Blood-brain barrier opening as a predictor of epilepsy and mortality after subarachnoid haemorrhage
Jens P Dreier, Svetlana Lublinsky, Viktor Horst, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 5, 2023
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury
Jan M Schwab, Carmen Haider, Marcel A Kopp, et al.
Page
of 44